Hims & Hers Health (XSWX:HIMS) ROC (Joel Greenblatt) %: -67.59% (As of Mar. 2026)


XSWX:HIMS Hims & Hers Health Inc XSWX:HIMS
81 GF Score
Price CHF29.90
GF Value CHF32.30
! 3 Warning Signs
View Full Analysis

What is Hims & Hers Health ROC (Joel Greenblatt) %?

Hims & Hers Health XSWX:HIMS 81 ROC (Joel Greenblatt) % is -67.59% as of Mar. 2026. GuruFocus rates XSWX:HIMS with a GF Score™ of 81/100 and a GF Value™ of CHF32.30. The stock has 3 warning signs investors should review. Among 977 Drug Manufacturers companies, Hims & Hers Health ranks worse than 75.95% on this metric.

Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits). He defines ROC (Joel Greenblatt) % as EBIT divided by the total of Property, Plant and Equipment and net working capital. Hims & Hers Health's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was -67.59%.

The historical rank and industry rank for Hims & Hers Health's ROC (Joel Greenblatt) % or its related term are showing as below:

XSWX:HIMS' s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: -2250.87   Med: -95.22   Max: 89.26
Current: -8.37

During the past 7 years, Hims & Hers Health's highest ROC (Joel Greenblatt) % was 89.26%. The lowest was -2250.87%. And the median was -95.22%.

XSWX:HIMS's ROC (Joel Greenblatt) % is ranked worse than
75.95% of 977 companies
in the Drug Manufacturers industry
Industry Median: 11.37 vs XSWX:HIMS: -8.37

Hims & Hers Health's 5-Year average Growth Rate of ROC (Joel Greenblatt) % was 0.00% per year.


Hims & Hers Health  (XSWX:HIMS) ROC (Joel Greenblatt) % Explanation

The way Joel Greenblatt defines Return on Capital is a more accurate measure of how efficiently the company generates returns onthe capital actually invested in the business. EBIT is used instead of net income because the tax and interest payment may be affected by factors other than the core business operation. Intangible assets are not included in the calculation because they don't need to be replaced.

Joel Greenblatt uses his definition of Return on Capital and Earnings Yield (Joel Greenblatt) % to rank companies.


Hims & Hers Health ROC (Joel Greenblatt) % Related Terms


Hims & Hers Health ROC (Joel Greenblatt) % Historical Data

* Premium members only.

The historical data trend for Hims & Hers Health's ROC (Joel Greenblatt) % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Hims & Hers Health ROC (Joel Greenblatt) % Chart

Hims & Hers Health Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
ROC (Joel Greenblatt) %
Get a 7-Day Free Trial -2,250.87 -646.68 -95.22 89.26 38.98

Hims & Hers Health Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
ROC (Joel Greenblatt) % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 148.99 43.18 13.81 8.59 -67.59

XSWX:HIMS vs : ROC (Joel Greenblatt) % Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Hims & Hers Health's ROC (Joel Greenblatt) %, along with its competitors' market caps and ROC (Joel Greenblatt) % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Hims & Hers Health ROC (Joel Greenblatt) % vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Hims & Hers Health's ROC (Joel Greenblatt) % distribution charts can be found below:

* The bar in red indicates where Hims & Hers Health's ROC (Joel Greenblatt) % falls into.


XSWX:HIMS
81GF Score
Hims & Hers Health Inc XSWX:HIMS
ROC (Joel Greenblatt) % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Hims & Hers Health ROC (Joel Greenblatt) % Calculation

Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits) . He defines Return on Capital as follows:

ROC (Joel Greenblatt) %=EBIT/Average of (Net fixed Assets + Net Working Capital)

EBIT stands for Earnings Before Interest and Taxes.

Fixed Assets are also known as non-current assets. They include the Property, Plant and Equipment that the firm needs in its operation.

GuruFocus calculates net working capital as: (Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Deferred Revenue + Other Current Liabilities). We're trying to account for OPERATING assets and liabilities (part of daily business) when calculating working capital. Cash and marketable securities are considered NON-OPERATING assets and are not included in calculation. We will also back out all interest bearing debt, short term debt and the portion of long term debt that is due in the current period from the current liabilities. This debt will be considered when computing cost of capital and it would be inappropriate to count it twice.

Working Capital(Q: Dec. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(32.149 + 80.128 + 77.869) - (268.782 + 127.16 + 3.646)
=-209.442

Working Capital(Q: Mar. 2026 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(149.62 + 79.073 + 65.795) - (437.704 + 165.132 + 10.362)
=-318.71

When net working capital is negative, 0 is used.

So ROC (Joel Greenblatt) % of Hims & Hers Health for the quarter that ended in Mar. 2026 can be restated as:

ROC (Joel Greenblatt) %(Q: Mar. 2026 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Dec. 2025  Q: Mar. 2026
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=-313.292/( ( (448.976 + max(-209.442, 0)) + (478.092 + max(-318.71, 0)) )/ 2 )
=-313.292/( ( 448.976 + 478.092 )/ 2 )
=-313.292/463.534
=-67.59 %

Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a ROC (Joel Greenblatt) % of -67.59% mean?
Hims & Hers Health (XSWX:HIMS) has a ROC (Joel Greenblatt) % of -67.59% as of Mar. 2026. Joel Greenblatt's return on capital is the ratio of EBIT to average fixed assets and net working capital. View historical data on Hims & Hers Health and its competitors. According to the industry distribution chart, Hims & Hers Health ranks #742 out of 977 companies in the Drug Manufacturers industry, placing it in the top 75.9%.
Is Hims & Hers Health's ROC (Joel Greenblatt) % too high?
Hims & Hers Health's current ROC (Joel Greenblatt) % is -67.59%. Based on the distribution chart, Hims & Hers Health ranks #742 out of 977 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Hims & Hers Health has a GF Score™ of 81/100, reflecting its overall financial health beyond just this single metric.
How does Hims & Hers Health's ROC (Joel Greenblatt) % compare to ?
According to the Drug Manufacturers industry distribution chart, Hims & Hers Health ranks #742 out of 977 companies for ROC (Joel Greenblatt) %. This places Hims & Hers Health in the lower half of its industry. The industry median ROC (Joel Greenblatt) % is 11.37. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROC (Joel Greenblatt) % for a Drug Manufacturers company?
The median ROC (Joel Greenblatt) % among Drug Manufacturers companies is 11.37, based on 977 companies in the industry. Companies in the top quartile (top 25%) have a ROC (Joel Greenblatt) % significantly above this median, while those in the bottom quartile fall well below. However, ROC (Joel Greenblatt) % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROC (Joel Greenblatt) % mean?
A high ROC (Joel Greenblatt) % can signal that a stock is expensive relative to its fundamentals. Joel Greenblatt's return on capital is the ratio of EBIT to average fixed assets and net working capital. View historical data on Hims & Hers Health and its competitors. For the Drug Manufacturers industry, the median ROC (Joel Greenblatt) % is 11.37 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Hims & Hers Health's current ROC (Joel Greenblatt) % is -67.59%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hims & Hers Health stock overvalued right now?
Hims & Hers Health (XSWX:HIMS) has a current ROC (Joel Greenblatt) % of -67.59%. The stock's GF Value™ is CHF32.30, compared to a current price of CHF29.90 — trading 7.4% below its estimated fair value. The current ROC (Joel Greenblatt) % is -67.59%. Hims & Hers Health's overall GF Score™ is 81/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROC (Joel Greenblatt) % calculated?
ROC (Joel Greenblatt) % is calculated from a company's financial statements. For Hims & Hers Health (XSWX:HIMS), the current ROC (Joel Greenblatt) % is -67.59% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Hims & Hers Health (XSWX:HIMS) Overvalued in 2026?

Based on GuruFocus' analysis, Hims & Hers Health stock appears to be undervalued. The current stock price of CHF29.90 is trading 7.4% below its estimated GF Value™ of CHF32.30.

Key valuation signals for XSWX:HIMS:

  • ROC (Joel Greenblatt) %: -67.59%
  • GF Value™: CHF32.30 vs. price of CHF29.90 (7.4% below fair value)
  • GF Score™: 81/100 with 3 warning signs

No single metric tells the full story. See the XSWX:HIMS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Hims & Hers Health Business Description

Comparable Companies
Address 2269 Chestnut Street, No. 523, San Francisco, CA, USA, 94123
Hims & Hers, launched in 2017, is a telehealth platform that connects patients and healthcare providers to offer treatment options for specialties like erectile dysfunction, hair loss, skin care, mental health, and weight loss. Its offerings include generic, branded, and compounded prescription drugs as well as over-the-counter medicines, cosmetics, and supplements. The platform, which has more than 2 million subscribers, is available in all 50 states and certain European markets like the UK. It includes provider networks, electronic medical records, cloud pharmacy fulfillment, and personalization capabilities. Hims does not take insurance and only accepts payments directly from customers.
81GF Score

Get the complete analysis for XSWX:HIMS

ROC (Joel Greenblatt) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF29.90
Price
CHF32.30
GF Value